Mibenratide

Mibenratide

SCHEMBL29534419

CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N2

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 4/20 0.68
▸ KLKB1 P03952 6/20 0.64
▸ TFPI P10646 4/20 0.63
▸ GABBR2 O75899 1/20 0.61
▸ GABBR1 Q9UBS5 1/20 0.61
▸ PCSK9 Q8NBP7 1/20 0.60
▸ ITGB3 P05106 1/20 0.60
▸ ITGB1 P05556 1/20 0.60
▸ ITGAV P06756 1/20 0.60
▸ ITGA5 P08648 1/20 0.60
▸ ITGB5 P18084 1/20 0.60
▸ PLG P00747 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cycloviolin D SCHEMBL30831405 0.90 ELANE (0.75) ELANEKLKB1TFPIGABBR2GABBR1
Palicourein SCHEMBL30178312 0.89 ELANE (0.76) ELANEKLKB1TFPIGABBR2GABBR1
Circulin C SCHEMBL29508755 0.87 ELANE (0.73) ELANEKLKB1TFPIGABBR2GABBR1
Cycloviolin B SCHEMBL30831402 0.87 ELANE (0.67) ELANEKLKB1TFPIPCSK9ITGB3
Violacin A SCHEMBL29519675 0.86 ELANE (0.70) ELANETFPIGABBR2GABBR1PCSK9
Cycloviolin C SCHEMBL30831410 0.86 ELANE (0.75) ELANEKLKB1TFPIGABBR2GABBR1
Circulin F SCHEMBL29508763 0.85 ELANE (0.69) ELANEKLKB1TFPIGABBR2GABBR1
Cycloviolacin O13 SCHEMBL30831409 0.85 ELANE (0.71) ELANEKLKB1TFPIPCSK9
Cycloviolin A SCHEMBL30831400 0.84 ELANE (0.71) ELANEKLKB1TFPIGABBR2GABBR1
SCHEMBL26935045 0.83 KRAS (0.58) ELANEKLKB1TFPIPCSK9ITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250295587-A1 COMPLEX LIPID NANOPARTICLES ENCAPSULATING POLYPEPTIDES AND USES THEREOF SAIL BIOMEDICINES, INC. 2025-09-25 — — US disclosed
EP-4529468-A1 FORMULATION OF API'S AND EXCIPIENT'S IN AN ICELL VIA HYDROPHOBIC ION PAIRING Danmarks Tekniske Universitet (DK) 2025-04-02 — — EP disclosed
EP-4529477-A1 POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS Danmarks Tekniske Universitet (DK) 2025-04-02 — — EP disclosed
US-20250051830-A1 MEMBRANE-EMBEDDED NANOPORE AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2025-02-13 — — US disclosed
US-20240398884-A1 PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF FLAGSHIP PIONEERING INNOVATIONS VI LLC (US) 2024-12-05 — — US disclosed
WO-2023227517-A1 FORMULATION OF API'S AND EXCIPIENT'S IN AN ICELL VIA HYDROPHOBIC ION PAIRING DANMARKS TEKNISKE UNIVERSITET (DK) 2023-11-30 — — WO disclosed
WO-2023227518-A1 POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS DANMARKS TEKNISKE UNIVERSITET (DK) 2023-11-30 — — WO disclosed
EP-4282448-A1 POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS Danmarks Tekniske Universitet (DK) 2023-11-29 — — EP disclosed
EP-4282435-A1 FORMULATIONS OF ACTIVE PHARMACEUTICAL INGREDIENTS AND EXCIPIENTS IN ICELLS VIA HYDROPHOBIC ION PAIRING Danmarks Tekniske Universitet (DK) 2023-11-29 — — EP disclosed
WO-2023064805-A1 MEMBRANE-EMBEDDED NANOPORE AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2023-04-20 — — WO disclosed
US-11459375-B2 Cyclic peptides for the treatment of Graves' disease ADVANCECOR GMBH (DE) 2022-10-04 — — US disclosed
US-20220288150-A1 PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF FLAGSHIP PIONEERING INNOVATIONS VI, LLC 2022-09-15 — — US disclosed
US-20220152139-A1 PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF FLAGSHIP PIONEERING INNOVATIONS VI, LLC 2022-05-19 — — US disclosed
Send feedback